loading page

Reduced TrkB signalling in Parvalbumin and Somatostatin positive interneurons have opposite effects on Sensorimotor Gating
  • Giuliano Didio,
  • Eero Castrén,
  • Juzoh Umemori
Giuliano Didio
University of Helsinki Helsinki Institute of Life Sciences
Author Profile
Eero Castrén
University of Helsinki Helsinki Institute of Life Sciences
Author Profile
Juzoh Umemori
University of Eastern Finland A I Virtanen Institute for Molecular Sciences

Corresponding Author:[email protected]

Author Profile


Parvalbumin-positive interneurons (PV-INs) and Somatostatin-positive interneurons (SST-INs) have emerged as key players in regulating network activity and plasticity in both healthy and diseased states. In particular, research has highlighted the involvement of interneurons in the development of various psychiatric disorders. We previously showed that TrkB activity in PV-INs plays a central role in the regulation of neuronal plasticity. This study investigates the role of TrkB in PV and SST interneurons and explores the validity of an interneuron-specific TrkB knockout mouse model. Mice with reduced TrkB expression in either PV-INs or SST-INs were generated to simulate an abnormal but not completely absent BDNF/TrkB pathway. By conducting behavioural battery, we observed that mice with impaired TrkB expression PV-INs exhibited a significant deficit in the Prepulse inhibition test (PPI), indicating altered sensorimotor gating. Conversely, TrkB knockout in SST-INs resulted in an opposite enhanced PPI effect, as well as a significantly shorter latency to enter the open arm in the elevated plus maze test, suggesting altered decision-making behaviour. These findings provide insights into the involvement of the BDNF/TrkB pathway in PV-INs and SST-INs, supporting the use of heterozygous TrkB knockout models in studying interneuron plasticity and network dynamics. Moreover, the altered sensorimotor gating observed in PV-INs highlights the potential of this model in understanding the sensorimotor abnormalities observed in schizophrenia.
03 Aug 2023Submitted to European Journal of Neuroscience
04 Aug 2023Assigned to Editor
04 Aug 2023Submission Checks Completed
04 Aug 2023Review(s) Completed, Editorial Evaluation Pending
14 Aug 2023Reviewer(s) Assigned